María Teresa Calvo - Concepedia

Author

María Teresa Calvo

Also Known As

Baselga, José, Blanca Garcia-Sandoval, M. Fernandez, M. T. Calvo, M.T. Calvo, Maria Teresa Calvo, Maria Teresa Calvo Fernandez, María Teresa Calvo, María Calvo, María T. Calvo

107

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Cornell University Memorial Sloan Kettering Cancer Center Hospital Universitario Miguel Servet Weill Cornell Medicine Universitat Autònoma de Barcelona

About

María Teresa Calvo is an author at Cornell University specializing in medicine, cell biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	556
2	Cell Biology	5	5	467
3	Health Sciences	3	3	70
4	Immunology	2	2	182
5	Molecular Genetics	2	2	47

María Teresa Calvo

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition Yasir H. Ibrahim, Celina García-García, Violeta Serra, Cancer Discovery	2012	611
EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis Wendy Béguelin, Matt Teater, Micah D. Gearhart, Cancer Cell Transcriptional RegulationDevelopmental BiologySignaling PathwayCell RegulationRepress Bivalent Promoters	2016	239
Defective TNF-α–mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice Carmen García‐Ruiz, Anna Colell, Albert Morales, Journal of Clinical Investigation	2003	223
EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop Wendy Béguelin, Martín A. Rivas, María Teresa Calvo, Nature Communications	2017	182
Activated Spinal Cord Ependymal Stem Cells Rescue Neurological Function Victoria Moreno‐Manzano, Francisco Javier Rodríguez-Jiménez, Mireia García-Roselló, Stem Cells	2009	160
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis Pilar M. Domínguez, Hussein Ghamlouch, Wojciech Rosikiewicz, Cancer Discovery	2018	159
Dual mTORC1/2 and HER2 Blockade Results in Antitumor Activity in Preclinical Models of Breast Cancer Resistant to Anti-HER2 Therapy Celina García-García, Yasir H. Ibrahim, Violeta Serra, Clinical Cancer Research	2012	156
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response Wendy Béguelin, Matt Teater, Cem Meydan, Cancer Cell Tumor BiologyLymphoid NeoplasiaMedicineImmunologyTumor Immunity	2020	146
An <i>In Vivo Kras</i> Allelic Series Reveals Distinct Phenotypes of Common Oncogenic Variants María Paz Zafra, Marie J. Parsons, Jangkyung Kim, Cancer Discovery	2020	126
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation Martín A. Rivas, Cem Meydan, Christopher R. Chin, Nature Immunology Cell RegulationB Cell TransitMedicineOncogenic AgentImmunology	2021	36

Page 1